The 3xTg-AD mouse, a widely investigated preclinical model of AD, has the benefit of exhibiting an age-related development of β-Amyloid (Aβ)- and tau-dependent pathology as well as AD-related synaptic dysfunction and cognitive impairment.15 Here, MAPT is linked to Alzheimer disease.